'Transcalciferin' (the serum transport protein for cholecalciferol and related substances) of two New World monkeys, Cebus apella and Cebus albifrons, was found to be immunologically identical with the transcalciferin of other monkeys and partially with that ofman. In contrast with the a-globulin mobility of the transcalciferin of other primates, the transcalciferin of cebus monkey has the electrophoretic mobility of albumin. Most of the serum 25-hydroxycholecalciferol was precipitable with isolated monospecific anti-(human transcalciferin) y-globulins but not with anti-(human albumin) y-globulins. These results indicate that the transport of 25-hydroxycholecalciferol in the cebus monkey is not due to albumin itself but to transcalciferin with the electrophoretic mobility of albumin. Similar variants of transcalciferin also exist in man.
Minderbroedersstraat 10, B-3000 Leuven, Belgium (Received25 March 1976) 'Transcalciferin' (the serum transport protein for cholecalciferol and related substances) of two New World monkeys, Cebus apella and Cebus albifrons, was found to be immunologically identical with the transcalciferin of other monkeys and partially with that ofman. In contrast with the a-globulin mobility of the transcalciferin of other primates, the transcalciferin of cebus monkey has the electrophoretic mobility of albumin. Most of the serum 25-hydroxycholecalciferol was precipitable with isolated monospecific anti-(human transcalciferin) y-globulins but not with anti-(human albumin) y-globulins. These results indicate that the transport of 25-hydroxycholecalciferol in the cebus monkey is not due to albumin itself but to transcalciferin with the electrophoretic mobility of albumin. Similar variants of transcalciferin also exist in man.
Cholecalciferol and 25-hydroxycholecalciferol [9,10-seco-cholesta-5,7,10(19) -triene-31,B25-diol] present in human serum are bound to plasma proteins, mainly a-globulins. This was first demonstrated (Thomas et al., 1959) by measuring the antirachitic activity of serum fractions and later confirmed by using labelled cholecalciferol (Avioli et al., 1968) or labelled 25-hydroxycholecalciferol (Haddad & Chyu, 1971) . This serum transport protein for ergocalciferol, cholecalciferol and their many hydroxylated derivatives has been isolated from human serum (Bouillon et al., 1976b) ; we tentatively term it 'transcalciferin', by analogy with other serum binding proteins (transcortin, transferrin and transcobalamin). During a comparative study of 25-hydroxycholecalciferolbinding protein in 72 mammalian species (Hay & Watson, 1976) , labelled 25-hydroxycholecalciferol was bound to a protein with a-globulin mobility on polyacrylamide-gel electrophoresis in all but seven species. In these seven exceptions, which included three species of New World monkeys (Cebus albifrons, Cebus capucinus and Cebus apella), 25-hydroxycholecalciferol was bound to a protein with the electrophoretic mobility of albumin. The same phenomenon was previously described for Cebus albifrons (Edelstein et aL, 1973) . Subsequently albumin itself was reported to be responsible for the transport of 25-hydroxycholecalciferol in these New World cebus monkeys (Hay, 1975 Antiserum production Antiserum to human transcalciferin was raised in rabbits as described by Bouillon et al. (1976b) .
Immunodiffusion Agarose (1 %, w/v) prepared in diethylbarbituric acid buffer (0.023M, pH8.6) was used for double immunodiffusion (Ouchterlony, 1949) and for the following electrophoresis and immunoelectrophoresis studies. Radial immunodiffusion was performed as previously described (Van Baelen & De Moor, 1974) by using either 0.3 ml of monospecific anti-(human transcalciferin) or 0.05 ml of monospecific anti-(human albumin) antiserum per IOml ofagarose.
Electrophoresis
Agarose-gel electrophoresis of serum (5p1l), previously incubated with 25-hydroxyPH]cholecalciferol (lOnCi) , was performed at 4°C during 3h at 15 V/cm. Thereafter half of the slide was stained with Amido Black and the other half cut into 0.25cm pieces and counted for radioactivity for 10min in 10ml of a toluene-based scintillator. Serum samples from three different species (man, and two species of monkey, Cebus apella and Aotus trivirgatus) were applied in three consecutive wells. After 1 h, the wells were closed with a drop of agarose and the first electrophoretic run (3 h, 15 V/cm, 4°C) was started. The second immunoelectrophoretic run was done at 4°C at 4V/cm for 20h. The immunogel (lOml) contained 0.4ml of a monospecific rabbit anti-(pure human transcalciferin) antiserum (Bouillon et al., 1976b) . Sucrose-gradient ultracentrifugation Ultracentrifugation of serum from man or Cebus apella was performed in a 5-20% (w/v) sucrose gradient (4.2ml prepared in sodium phosphate buffer, I=0.2, pH7.4) at 240000g for 15h at4°C in a swingout bucket of a MSE Superspeed 65 ultracentrifuge. The applied serum sample (0.2ml) was diluted with the same buffer, either twofold for radialimmunodiffusion studies or 20-fold for radioactivity measurements, after previous incubation ofthe serum with a trace amount of 25-hydroxy[3H]cholecalciferol and 14C-labelled bovine serum albumin, as prepared by Rice & Means (1971) .
Immunoprecipitation
Immunoprecipitation of 25-hydroxy[3H]cholecalciferol-labelledserumwasperformedwithy-globulins, precipitated from whole rabbit antiserum with (NH4)2SO4 (20%, w/v) and further purified by Sephadex G-75 gelfiltration on a4cm x 20cmcolumn, eluted with phosphate buffer (0.05M, pH7.4). The final incubation mixture of 1 ml consisted of serum (diluted 500-fold) from man or Cebus apella, lOnCi of 25-hydroxy[3H]cholecalciferol and serial dilution of y-globulins (from 4 to 0.04mg/ml). After 20h incubation at 4°C the tubes were centrifuged (20000g for 20min) and 0.5ml of the supernatant was counted for radioactivity for 10min.
Measurements of radioactivity
Radioactivity was measured in a Packard model 2450 spectrometer in either a toluene scintillator (Bouillon et al., 1976a) or Insta-Gel (Packard Instruments, Downers Grove, IL, U.S.A.). (ii Immunoelectrophoresis (a) and tandem crossed immunoelectrophoresis (b) of serum from man, Cebus apella and Aotus trivirgatus Serum from man (S,ul), Cebus apella (7,pl) and Aotus trivirgatus (5,pl) was applied in three consecutive wells with a distance between centres of 1 cm. The immunogel in the tandem crossed electrophoresis (a) and the trough in the immunoelectrophoresis (b) contain monospecific anti-(human transcalciferin) antiserum. The distance between the first and the second peak of immunoprecipitation is 1.4cm, and between the first and the third, 3.05 cm. For details, see the text. The monospecificity of our anti-(human transcalciferin) antiserum has previously been demonstrated (Bouillon et al., 1976b) (Hay, 1975; Hay & Watson, 1975) .
(b) Transcalciferin is smaller than albumin. The sedimentation coefficient of transcalciferin from Cebus apella was 4.1 S (Fig. Ia) . This value is identical with that obtained in man (Bouillon et al., 1976b) . Accordingly, these proteins are smaller than human or bovine serum albumin (4.6S). It was also shown, by immunochemical localization of transcalciferin and albumin, that both proteins do not coincide after sucrose-gradient ultracentrifugation of serum of Cebus apella (Fig. lb) .
(c) Transcalciferin of the cebus monkey has an increased electrophoretic mobility. On agarose-gel electrophoresis 25-hydroxy[3H]cholecalciferol added to the serum of Cebus apella (or Cebus albifrons) is bound to a protein with a greater mobility than the corresponding protein present in human serum (Fig. 2) . This confirms previous reports (Edelstein et al., 1973; Hay & Watson, 1976 ) that in all Cebus species (Cebus apella, Cebus albifrons and Cebus capucinus) 25-hydroxycholecalciferol is bound to a transport protein with the mobility of albumin. By using immunochemical detection of the transport protein on tandem crossed immunoelectrophoresis (Plate 2), it is evident that the transcalciferin from man and Aotus trivirgatus have the same electrophoretic mobility, since the distance of 3 cm between their respective application wells is identical with the distance between their peaks in the immunogel. The increased mobility of transcalciferin of Cebus apella compared with that of man is demonstrated by the distance of 1.4cm between their immunoprecipitation peaks, whereas the distance between their respective application wells is only 1 cm. Discussion Hay (1975) reported that albumin itself was responsible for the transport of 25-hydroxycholecalciferol in the cebus monkey, because he was unable to dissociate 25-hydroxy[3H]cholecalciferol from the serum albumin peak during electrophoresis or gel filtration. This premature conclusion can now be explained, since we demonstrated that the cebus transcalciferin (from Cebus apella or Cebus albifrons) has indeed the electrophoretic mobility of albumin and that both proteins have only a small difference in molecular size. There can, however, be no doubt that these monkeys have a serum protein that is immunologically related to the transcalciferin of other primates and is able to bind most of the serum 25-hydroxycholecalciferol.
The phenomenon of altered electrophoretic mobility of transcalciferin not only exists in these New World monkeys but also in the human species. Indeed, several variants of group-specific components of human serum with altered electrophoretic mobility have been described [for a review, see Cleve (1973) ]. This group-specific globulin is now known to be identical with transcalciferin (Daiger et a!., 1975; Bouillon et al., 1976b) .
The reason for the variation in electrophoretic mobility is, however, still unclear, since the molecular weight and the isoelectric point (H. Van Baelen & R. Bouillon, unpublished work) of transcalciferin, as studied by means of 25-hydroxy-
[3H]cholecalciferol, are identical in man and Cebus apella.
